142Indexed trials
mesh condition
Multiple Sclerosis
Intelligence
Multiple Sclerosis intelligence: 142 indexed trials, 29 recruiting studies, 107 sponsors across 70 countries.
29Recruiting
107Sponsors
70Countries
Leading sponsors
Hoffmann-La Roche51 recruiting
Teva Neuroscience, Inc.40 recruiting
Biogen40 recruiting
Celgene40 recruiting
Brigham and Women's Hospital31 recruiting
University Hospital, Basel, Switzerland32 recruiting
Genzyme, a Sanofi Company30 recruiting
IRCCS San Camillo, Venezia, Italy22 recruiting
IRCCS San Raffaele20 recruiting
Charles University, Czech Republic20 recruiting
Cinnagen20 recruiting
Cairo University20 recruiting
Geographic activity
United States54trials
Italy21trials
Spain17trials
Poland16trials
Canada16trials
United Kingdom16trials
France15trials
Switzerland14trials
Czechia13trials
Belgium12trials
Germany12trials
Denmark11trials
Leading interventions
Ocrelizumab7trials
Methylprednisolone2trials
Interferon beta-1a2trials
RPC10632trials
Nabiximols2trials
Alemtuzumab Injection [Lemtrada]1trials
Alemtuzumab 24 mg1trials
Aerobic training compared to conventional motor training1trials
Avonex prefilled syringe via manual IM injection1trials
Autologous HB-adMSCs1trials
BG9418 (interferon beta-1a)1trials
Alemtuzumab 12 mg1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.